Pradaxa Lawsuit News: The Number of Pradaxa Lawsuits Filed Under the Pradaxa MDL Increased 40% in Recent Months

Pradaxa lawsuit co-liaison counsel at The Onder Law Firm announces that the number of individual Pradaxa lawsuits filed against pharmaceutical giant Boehringer Ingleheim increased forty percent between July and October 2013 as new bleeding injuries occur and more families of those suffering severe internal bleeding after using Pradaxa come forward.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friendRepost This
Mark Niemeyer

Mark Niemeyer

As of July 10, 2013, 1172 individual Pradaxa lawsuits had been filed; that number rose to 1643 in the October 17, 2013 report, representing a 40% increase in Pradaxa lawsuits a mere three months.

St. Louis, MO (PRWEB) October 30, 2013

The Onder Law Firm has announced that statistics released by the U.S. Judicial Panel on Multi District Litigation this month reveal that Pradaxa internal bleeding lawsuits (MDL No. 2385, United States District Court, Southern District of Illinois) are mounting rapidly against the German pharmaceutical company, Boehringer Ingleheim. As of July 10, 2013, 1172 individual Pradaxa lawsuits had been filed; that number rose to 1643 in the October 17, 2013 report, representing a 40% increase in Pradaxa lawsuits a mere three months.

Pradaxa lawsuits have been filed as Multi-District Litigation (MDL) suits. This is a procedure designed to expedite the processing of large numbers of separate suits filed for similar grievances. This is not the same as a class action lawsuit, which is typically used to resolve less serious complaints. Severe internal bleeding and death are the subjects of the Pradaxa Products Liability Litigation.

Currently under investigation by the FDA and European public health entities, Pradaxa has been linked to a higher-than-expected risk for severe internal bleeding incidents and deaths. Preparations are under way for an August 11, 2014 start for a bellweather Pradaxa internal bleeding lawsuit trial.

The lawyers at Onder, Shelton, O'Leary & Peterson working on the Pradaxa lawsuit are offering a free case review with no further obligation to the families of persons who experienced severe internal bleeding after using Pradaxa. The firm is representing all persons who file a Pradaxa lawsuit on a contingency basis with no cost to the client unless they successfully win compensation for them. Although the firm is centrally located in St. Louis, Missouri, it represents clients throughout the United States. St. Louis is the closest metropolitan area to the court handling the Pradaxa Products Liability Litigation.

About The Onder Law Firm
Onder, Shelton, O’Leary & Peterson, LLC is a St. Louis based personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. Onder, Shelton, O’Leary & Peterson has represented clients throughout the United States, and other firms throughout the nation often seek its experience and expertise on complex litigation. It is a recognized leader in products liability cases such as window blind cord strangulation and pharmaceutical litigation. The Onder Law Firm offers information pertaining to Pradaxa internal bleeding dangers at http://www.pradaxalawsuitcenter.com.


Contact